RANI
NASDAQ · Pharmaceuticals
Rani Therapeutics Holdings-A
$0.86
+0.01 (+1.22%)
Open$0.85
Previous Close$0.85
Day High$0.86
Day Low$0.82
52W High$3.87
52W Low$0.45
Volume—
Avg Volume533.8K
Market Cap111.52M
P/E Ratio—
EPS$-0.26
SectorPharmaceuticals
Analyst Ratings
Strong Buy
11 analysts
Price Target
+4,209.7% upside
Current
$0.86
$0.86
Target
$37.15
$37.15
$30.65
$37.15 avg
$44.71
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 3.35M | 3.97M | 51.04M |
| Net Income | -60,872,678 | -64,942,401 | 8.38M |
| Profit Margin | -1,817.1% | -1,726.2% | 16.4% |
| EBITDA | -77,912,144 | -87,738,900 | 12.88M |
| Free Cash Flow | — | — | 6.14M |
| Rev Growth | -15.6% | -15.6% | +13.5% |
| Debt/Equity | — | — | 0.99 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,164.89 | +1.04% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.47 | -0.19% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $149.50 | +1.79% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.74 | +0.29% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.62 | -0.70% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $71.33 | -0.10% | 11.5 | 30.15B |